Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-23

Clinical Trial Update: Use of ST250 to Reconstruct Lateral Tongue Defects

View source ↗

Summary

A clinical trial evaluating ST250 for reconstruction of lateral tongue defects after tumor resection in tongue neoplasms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ST250

Snippet

Sponsor: Cairo University | Conditions: Tongue Neoplasms | Status: COMPLETED